Novel Polymorphic Form Of Imatinib Mesylate And A Process For Its Preparation

Patent No. EP1720853 (titled "Novel Polymorphic Form Of Imatinib Mesylate And A Process For Its Preparation") was filed by Adibhatla on Nov 16, 2004. The application was issued on Jun 28, 2023.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ACAPO ONSAGERSSep 30, 2016ACAPO ONSAGERS
GIZINSKA SCHOHESep 30, 2016HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1720853

ADIBHATLA
Application Number
EP04806748A
Filing Date
Nov 16, 2004
Status
Patent Maintained As Amended
May 26, 2023
Publication Date
Jun 28, 2023